Literature DB >> 24002048

Advances in Hirschsprung disease genetics and treatment strategies: an update for the primary care pediatrician.

Deepika D'Cunha Burkardt1, John M Graham, Scott S Short, Philip K Frykman.   

Abstract

Hirschsprung disease (HSCR) is a multigenic condition with variable presentation. Most commonly, it presents in the neonatal period as a functional intestinal obstruction secondary to failure of caudal migration of the enteric nervous system. Classically, this manifests as dilated proximal bowel and constricted distal bowel with absent ganglia and hypertrophic nerve trunks. When recognized early, medical and surgical therapies can be instituted to minimize associated morbidity and mortality. This article reviews current understanding of the etiology of HSCR, its multigenic associations, the historical evolution of HSCR diagnosis and treatment, and current HSCR therapies.

Entities:  

Keywords:  Hirschsprung disease; Hirschsprung-associated enterocolitis; aganglionosis; congenital megacolon; enteric nervous system; genetics; intestinal neuronal dysplasia

Mesh:

Substances:

Year:  2013        PMID: 24002048     DOI: 10.1177/0009922813500846

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  13 in total

1.  Self-reported race and ethnicity of US biobank participants compared to the US Census.

Authors:  Elizabeth Gross Cohn; Nalo Hamilton; Elaine L Larson; Janet K Williams
Journal:  J Community Genet       Date:  2017-06-16

2.  Regeneration: Stem cells make the bowel nervous.

Authors:  Robert O Heuckeroth
Journal:  Nature       Date:  2016-02-10       Impact factor: 49.962

3.  Genome-wide association study of Hirschsprung disease detects a novel low-frequency variant at the RET locus.

Authors:  João Fadista; Marie Lund; Line Skotte; Frank Geller; Priyanka Nandakumar; Sumantra Chatterjee; Hans Matsson; Anna Löf Granström; Tomas Wester; Perttu Salo; Valtter Virtanen; Lisbeth Carstensen; Jonas Bybjerg-Grauholm; David Michael Hougaard; Mikko Pakarinen; Markus Perola; Agneta Nordenskjöld; Aravinda Chakravarti; Mads Melbye; Bjarke Feenstra
Journal:  Eur J Hum Genet       Date:  2018-01-29       Impact factor: 4.246

4.  Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease.

Authors:  Jian Wang; Hao Du; Ya-Ru Mou; Jian-Yi Niu; Wen-Tong Zhang; Hong-Chao Yang; Ai-Wu Li
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

5.  Hirschsprung's disease - Postsurgical intestinal dysmotility.

Authors:  Mariana Tresoldi das Neves Romaneli; Antonio Fernando Ribeiro; Joaquim Murray Bustorff-Silva; Rita Barbosa de Carvalho; Elizete Aparecida Lomazi
Journal:  Rev Paul Pediatr       Date:  2016-02-18

6.  Characterization of Intestinal Microbiomes of Hirschsprung's Disease Patients with or without Enterocolitis Using Illumina-MiSeq High-Throughput Sequencing.

Authors:  Yuqing Li; Valeriy Poroyko; Zhilong Yan; Liya Pan; Yi Feng; Peihua Zhao; Zhoulonglong Xie; Li Hong
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

7.  Abundance and Significance of Neuroligin-1 and Neurexin II in the Enteric Nervous System of Embryonic Rats.

Authors:  Dongming Wang; Jingnian Pan; Guoxin Song; Ni Gao; Yi Zheng; Qiangye Zhang; Aiwu Li
Journal:  Biomed Res Int       Date:  2017-01-18       Impact factor: 3.411

8.  miR-618 rs2682818 C>A polymorphism decreases Hirschsprung disease risk in Chinese children.

Authors:  Yi Zheng; Tongyi Lu; Xiaoli Xie; Qiuming He; Lifeng Lu; Wei Zhong
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

9.  Association between DSCAM polymorphisms and non-syndromic Hirschsprung disease in Chinese population.

Authors:  Yong Wang; Qiuming He; Ruizhong Zhang; Wei Zhong; Deli Zhu; Yan Zhang; Huimin Xia
Journal:  BMC Med Genet       Date:  2018-07-13       Impact factor: 2.103

10.  Microbiome Composition in Both Wild-Type and Disease Model Mice Is Heavily Influenced by Mouse Facility.

Authors:  Kristopher D Parker; Shannon E Albeke; Jason P Gigley; Allan M Goldstein; Naomi L Ward
Journal:  Front Microbiol       Date:  2018-07-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.